Perm1 Gene Therapy Mitigates PRDM16-Associated Cardiomyopathy
Omid Mohammad Tavakoli‐Rouzbehani, Sophie L. Stephens, Benjamin Werbner…·Sihem Boudina
This study identifies PERM1 as a downstream target of PRDM16 and shows that Perm1 gene therapy improves cardiomyopathy in Prdm16 knockout mice through mitochondrial and sarcomere preservation.